Search research articles
Contact Us
Filters
Showing results (1-10 of 30) with videos related to
Page
of 3
Sort By:
Journal of Clinical Pharmacology
|
March 26, 2009
Kerfuffle!
Thaddeus H Grasela, Elizabeth Ludwig, Jill Fiedler-Kelly
Journal of Clinical Pharmacology
|
July 21, 2016
Population Pharmacokinetic Modeling of Armodafinil and Its Major Metabolites
Susan Willavize, Jill Fiedler-Kelly, Elizabeth Ludwig, et al.
Pharmaceutics
|
June 2, 2021
Scaling Approaches for Pediatric Dose Selection: The Fremanezumab (AJOVY<sup>®</sup>) Journey to Select a Phase 3 Dose Using Pharmacokinetic Data from a Phase 1 Study
Aksana Jones, Orit Cohen-Barak, Andrijana Radivojevic, et al.
Journal of Clinical Pharmacology
|
December 3, 2022
Immunogenicity Considerations for Therapeutic Modalities Used in Rare Diseases
Anas M Fathallah, Philip Oldfield, Jill Fiedler-Kelly, et al.
Plos One
|
July 11, 2013
A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis
Himanshu Naik, Max C Tsai, Jill Fiedler-Kelly, et al.
Headache
|
May 24, 2020
Effect of Fremanezumab Monthly and Quarterly Doses on Efficacy Responses
Jill Fiedler-Kelly, Julie Passarell, Elizabeth Ludwig, et al.
The AAPS Journal
|
June 11, 2014
Population pharmacokinetic modeling of LY2189102 after multiple intravenous and subcutaneous administrations
Sébastien Bihorel, Jill Fiedler-Kelly, Elizabeth Ludwig, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
June 28, 2018
Modeling and simulations to support dose selection for eslicarbazepine acetate therapy in pediatric patients with partial-onset seizures
Soujanya Sunkaraneni, Elizabeth Ludwig, Jill Fiedler-Kelly, et al.
Clinical Pharmacology and Therapeutics
|
April 7, 2023
Dabigatran Dosing Proposal for Adults With Atrial Fibrillation: Stress-Testing Renal Function Range in Real World Patients
J Robert Powell, Farah Al Qaraghuli, Jill Fiedler-Kelly, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
March 21, 2014
A comparison of the pharmacokinetic profile of an ascending-dose, extended-regimen combined oral contraceptive to those of other extended regimens
Mona Darwish, Mary Bond, Nancy Ricciotti, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 30) with videos related to
Sort By:
Page
of 3
Journal of Clinical Pharmacology
|
March 26, 2009
Kerfuffle!
Thaddeus H Grasela, Elizabeth Ludwig, Jill Fiedler-Kelly
Journal of Clinical Pharmacology
|
July 21, 2016
Population Pharmacokinetic Modeling of Armodafinil and Its Major Metabolites
Susan Willavize, Jill Fiedler-Kelly, Elizabeth Ludwig, et al.
Pharmaceutics
|
June 2, 2021
Scaling Approaches for Pediatric Dose Selection: The Fremanezumab (AJOVY<sup>®</sup>) Journey to Select a Phase 3 Dose Using Pharmacokinetic Data from a Phase 1 Study
Aksana Jones, Orit Cohen-Barak, Andrijana Radivojevic, et al.
Journal of Clinical Pharmacology
|
December 3, 2022
Immunogenicity Considerations for Therapeutic Modalities Used in Rare Diseases
Anas M Fathallah, Philip Oldfield, Jill Fiedler-Kelly, et al.
Plos One
|
July 11, 2013
A Population Pharmacokinetic and Pharmacodynamic Analysis of Peginesatide in Patients with Chronic Kidney Disease on Dialysis
Himanshu Naik, Max C Tsai, Jill Fiedler-Kelly, et al.
Headache
|
May 24, 2020
Effect of Fremanezumab Monthly and Quarterly Doses on Efficacy Responses
Jill Fiedler-Kelly, Julie Passarell, Elizabeth Ludwig, et al.
The AAPS Journal
|
June 11, 2014
Population pharmacokinetic modeling of LY2189102 after multiple intravenous and subcutaneous administrations
Sébastien Bihorel, Jill Fiedler-Kelly, Elizabeth Ludwig, et al.
Journal of Pharmacokinetics and Pharmacodynamics
|
June 28, 2018
Modeling and simulations to support dose selection for eslicarbazepine acetate therapy in pediatric patients with partial-onset seizures
Soujanya Sunkaraneni, Elizabeth Ludwig, Jill Fiedler-Kelly, et al.
Clinical Pharmacology and Therapeutics
|
April 7, 2023
Dabigatran Dosing Proposal for Adults With Atrial Fibrillation: Stress-Testing Renal Function Range in Real World Patients
J Robert Powell, Farah Al Qaraghuli, Jill Fiedler-Kelly, et al.
Reproductive Sciences (Thousand Oaks, Calif.)
|
March 21, 2014
A comparison of the pharmacokinetic profile of an ascending-dose, extended-regimen combined oral contraceptive to those of other extended regimens
Mona Darwish, Mary Bond, Nancy Ricciotti, et al.
Page
of 3